0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Regenerative Medicine Sales Market Report 2023
Published Date: January 2023
|
Report Code: QYRE-Auto-17176
Home | Market Reports | Health| Nursing
Global Regenerative Medicine Market Size Status and Forecast 2022
BUY CHAPTERS

Global Regenerative Medicine Sales Market Report 2023

Code: QYRE-Auto-17176
Report
January 2023
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Regenerative Medicine Market 2023

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
 
Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and “the vanguard of 21st century healthcare” by the U.S. Department of Health and Human Services.
 
 
Due to the COVID-19 pandemic, the global Regenerative Medicine market size is estimated to be worth US$ 33370 million in 2022 and is forecast to a readjusted size of US$ 115660 million by 2029 with a CAGR of 19.2% during the forecast period 2023-2029.
 
Regenerative Medicine market
Fully considering the economic change by this health crisis, Cell Therapy accounting for % of the Regenerative Medicine global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029.
 
While Dermatology segment is altered to an % CAGR throughout this forecast period.
Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.
North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent.
 
In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.
 
 
The global Regenerative Medicine market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2018-2029.
 

Scope of Global Regenerative Medicine  Market Report

Report Metric Details
Report Name Global Regenerative Medicine Market
Base Year 2022
Forecasted years 2023-2029
By Company
  • J & J (DePuy Synthes)
  • Medtronic
  • Zimmer Biomet
  • Stryker
  • Allergan(Acelity)
  • MiMedx Group
  • Organogenesis
  • Fujifilm Cellular Dynamics
  • Osiris Therapeutics
  • Vcanbio
  • CCBC
  • Cytori
  • Celgene
  • Vericel Corporation
  • Guanhao Biotech
  • Mesoblast
  • AMAG Pharmaceuticals (CBR)
  • ViaCord
  • CordLife
  • Integra LifeSciences
  • Nuvasive
  • Cook Biotech
  • Japan Tissue Engineering
Segment by Type
  • Cell Therapy
  • Tissue Engineering
  • Biomaterial
  • Other
Segment by Application
  • Dermatology
  • Cardiovascular
  • CNS
  • Orthopedic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Medicine Market Size by Type (2018 VS 2022 VS 2029)
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Biomaterial
1.2.5 Other
1.3 Market by Application
1.3.1 Global Regenerative Medicine Market Share by Application (2018 VS 2022 VS 2029)
1.3.2 Dermatology
1.3.3 Cardiovascular
1.3.4 CNS
1.3.5 Orthopedic
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Medicine Market Perspective (2018-2029)
2.2 Global Regenerative Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.3 Global Regenerative Medicine Revenue Market Share by Region (2018-2023)
2.4 Global Regenerative Medicine Revenue Forecast by Region (2024-2029)
2.5 Geographic Market Analysis: Market Facts & Figures
2.5.1 United States Regenerative Medicine Estimates and Projections (2018-2029)
2.5.2 Europe Regenerative Medicine Estimates and Projections (2018-2029)
2.5.3 China Regenerative Medicine Estimates and Projections (2018-2029)
2.5.4 Japan Regenerative Medicine Estimates and Projections (2018-2029)
2.5.5 Southeast Asia Regenerative Medicine Estimates and Projections (2018-2029)
2.5.6 India Regenerative Medicine Estimates and Projections (2018-2029)
3 Global Regenerative Medicine Competition Landscape by Players
3.1 Global Top Regenerative Medicine Players by Revenue (2018-2023)
3.1.1 Global Top Regenerative Medicine Players by Revenue (2018-2023)
3.1.2 Global Regenerative Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Regenerative Medicine Revenue
3.4 Global Regenerative Medicine Market Concentration Ratio
3.4.1 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Medicine Revenue in 2022
3.5 Regenerative Medicine Key Players Head office and Area Served
3.6 Key Players Regenerative Medicine Product Solution and Service
3.7 Date of Enter into Regenerative Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Regenerative Medicine Breakdown Data by Type
4.1 Global Regenerative Medicine Historic Market Size by Type (2018-2023)
4.2 Global Regenerative Medicine Forecasted Market Size by Type (2024-2029)
5 Regenerative Medicine Breakdown Data by Application
5.1 Global Regenerative Medicine Historic Market Size by Application (2018-2023)
5.2 Global Regenerative Medicine Forecasted Market Size by Application (2024-2029)
6 United States Regenerative Medicine Market Facts & Figures
6.1 United States Regenerative Medicine Revenue by Company (2018-2023)
6.2 United States Regenerative Medicine Market Size by Type
6.2.1 United States Regenerative Medicine Market Size by Type (2018-2023)
6.2.2 United States Regenerative Medicine Market Size by Type (2024-2029)
6.2.3 United States Regenerative Medicine Market Share by Type (2018-2029)
6.3 United States Regenerative Medicine Market Size by Application
6.3.1 United States Regenerative Medicine Market Size by Application (2018-2023)
6.3.2 United States Regenerative Medicine Market Size by Application (2024-2029)
6.3.3 United States Regenerative Medicine Market Share by Application (2018-2029)
7 Europe Regenerative Medicine Market Facts & Figures
7.1 Europe Regenerative Medicine Revenue by Company (2018-2023)
7.2 Europe Regenerative Medicine Market Size by Type
7.2.1 Europe Regenerative Medicine Market Size by Type (2018-2023)
7.2.2 Europe Regenerative Medicine Market Size by Type (2024-2029)
7.2.3 Europe Regenerative Medicine Market Share by Type (2018-2029)
7.3 Europe Regenerative Medicine Market Size by Application
7.3.1 Europe Regenerative Medicine Market Size by Application (2018-2023)
7.3.2 Europe Regenerative Medicine Market Size by Application (2024-2029)
7.3.3 Europe Regenerative Medicine Market Share by Application (2018-2029)
8 China Regenerative Medicine Market Facts & Figures
8.1 China Regenerative Medicine Revenue by Company (2018-2023)
8.2 China Regenerative Medicine Market Size by Type
8.2.1 China Regenerative Medicine Market Size by Type (2018-2023)
8.2.2 China Regenerative Medicine Market Size by Type (2024-2029)
8.2.3 China Regenerative Medicine Market Share by Type (2018-2029)
8.3 China Regenerative Medicine Market Size by Application
8.3.1 China Regenerative Medicine Market Size by Application (2018-2023)
8.3.2 China Regenerative Medicine Market Size by Application (2024-2029)
8.3.3 China Regenerative Medicine Market Share by Application (2018-2029)
9 Japan Regenerative Medicine Market Facts & Figures
9.1 Japan Regenerative Medicine Revenue by Company (2018-2023)
9.2 Japan Regenerative Medicine Market Size by Type
9.2.1 Japan Regenerative Medicine Market Size by Type (2018-2023)
9.2.2 Japan Regenerative Medicine Market Size by Type (2024-2029)
9.2.3 Japan Regenerative Medicine Market Share by Type (2018-2029)
9.3 Japan Regenerative Medicine Market Size by Application
9.3.1 Japan Regenerative Medicine Market Size by Application (2018-2023)
9.3.2 Japan Regenerative Medicine Market Size by Application (2024-2029)
9.3.3 Japan Regenerative Medicine Market Share by Application (2018-2029)
10 Southeast Asia Regenerative Medicine Market Facts & Figures
10.1 Southeast Asia Regenerative Medicine Revenue by Company (2018-2023)
10.2 Southeast Asia Regenerative Medicine Market Size by Type
10.2.1 Southeast Asia Regenerative Medicine Market Size by Type (2018-2023)
10.2.2 Southeast Asia Regenerative Medicine Market Size by Type (2024-2029)
10.2.3 Southeast Asia Regenerative Medicine Market Share by Type (2018-2029)
10.3 Southeast Asia Regenerative Medicine Market Size by Application
10.3.1 Southeast Asia Regenerative Medicine Market Size by Application (2018-2023)
10.3.2 Southeast Asia Regenerative Medicine Market Size by Application (2024-2029)
10.3.3 Southeast Asia Regenerative Medicine Market Share by Application (2018-2029)
11 India Regenerative Medicine Market Facts & Figures
11.1 India Regenerative Medicine Revenue by Company (2018-2023)
11.2 India Regenerative Medicine Market Size by Type
11.2.1 India Regenerative Medicine Market Size by Type (2018-2023)
11.2.2 India Regenerative Medicine Market Size by Type (2024-2029)
11.2.3 India Regenerative Medicine Market Share by Type (2018-2029)
11.3 India Regenerative Medicine Market Size by Application
11.3.1 India Regenerative Medicine Market Size by Application (2018-2023)
11.3.2 India Regenerative Medicine Market Size by Application (2024-2029)
11.3.3 India Regenerative Medicine Market Share by Application (2018-2029)
12 Key Players Profiles
12.1 J & J (DePuy Synthes)
12.1.1 J & J (DePuy Synthes) Company Details
12.1.2 J & J (DePuy Synthes) Business Overview
12.1.3 J & J (DePuy Synthes) Regenerative Medicine Introduction
12.1.4 J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2018-2023)
12.1.5 J & J (DePuy Synthes) Recent Development
12.2 Medtronic
12.2.1 Medtronic Company Details
12.2.2 Medtronic Business Overview
12.2.3 Medtronic Regenerative Medicine Introduction
12.2.4 Medtronic Revenue in Regenerative Medicine Business (2018-2023)
12.2.5 Medtronic Recent Development
12.3 Zimmer Biomet
12.3.1 Zimmer Biomet Company Details
12.3.2 Zimmer Biomet Business Overview
12.3.3 Zimmer Biomet Regenerative Medicine Introduction
12.3.4 Zimmer Biomet Revenue in Regenerative Medicine Business (2018-2023)
12.3.5 Zimmer Biomet Recent Development
12.4 Stryker
12.4.1 Stryker Company Details
12.4.2 Stryker Business Overview
12.4.3 Stryker Regenerative Medicine Introduction
12.4.4 Stryker Revenue in Regenerative Medicine Business (2018-2023)
12.4.5 Stryker Recent Development
12.5 Allergan(Acelity)
12.5.1 Allergan(Acelity) Company Details
12.5.2 Allergan(Acelity) Business Overview
12.5.3 Allergan(Acelity) Regenerative Medicine Introduction
12.5.4 Allergan(Acelity) Revenue in Regenerative Medicine Business (2018-2023)
12.5.5 Allergan(Acelity) Recent Development
12.6 MiMedx Group
12.6.1 MiMedx Group Company Details
12.6.2 MiMedx Group Business Overview
12.6.3 MiMedx Group Regenerative Medicine Introduction
12.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2018-2023)
12.6.5 MiMedx Group Recent Development
12.7 Organogenesis
12.7.1 Organogenesis Company Details
12.7.2 Organogenesis Business Overview
12.7.3 Organogenesis Regenerative Medicine Introduction
12.7.4 Organogenesis Revenue in Regenerative Medicine Business (2018-2023)
12.7.5 Organogenesis Recent Development
12.8 Fujifilm Cellular Dynamics
12.8.1 Fujifilm Cellular Dynamics Company Details
12.8.2 Fujifilm Cellular Dynamics Business Overview
12.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Introduction
12.8.4 Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2018-2023)
12.8.5 Fujifilm Cellular Dynamics Recent Development
12.9 Osiris Therapeutics
12.9.1 Osiris Therapeutics Company Details
12.9.2 Osiris Therapeutics Business Overview
12.9.3 Osiris Therapeutics Regenerative Medicine Introduction
12.9.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2018-2023)
12.9.5 Osiris Therapeutics Recent Development
12.10 Vcanbio
12.10.1 Vcanbio Company Details
12.10.2 Vcanbio Business Overview
12.10.3 Vcanbio Regenerative Medicine Introduction
12.10.4 Vcanbio Revenue in Regenerative Medicine Business (2018-2023)
12.10.5 Vcanbio Recent Development
12.11 CCBC
12.11.1 CCBC Company Details
12.11.2 CCBC Business Overview
12.11.3 CCBC Regenerative Medicine Introduction
12.11.4 CCBC Revenue in Regenerative Medicine Business (2018-2023)
12.11.5 CCBC Recent Development
12.12 Cytori
12.12.1 Cytori Company Details
12.12.2 Cytori Business Overview
12.12.3 Cytori Regenerative Medicine Introduction
12.12.4 Cytori Revenue in Regenerative Medicine Business (2018-2023)
12.12.5 Cytori Recent Development
12.13 Celgene
12.13.1 Celgene Company Details
12.13.2 Celgene Business Overview
12.13.3 Celgene Regenerative Medicine Introduction
12.13.4 Celgene Revenue in Regenerative Medicine Business (2018-2023)
12.13.5 Celgene Recent Development
12.14 Vericel Corporation
12.14.1 Vericel Corporation Company Details
12.14.2 Vericel Corporation Business Overview
12.14.3 Vericel Corporation Regenerative Medicine Introduction
12.14.4 Vericel Corporation Revenue in Regenerative Medicine Business (2018-2023)
12.14.5 Vericel Corporation Recent Development
12.15 Guanhao Biotech
12.15.1 Guanhao Biotech Company Details
12.15.2 Guanhao Biotech Business Overview
12.15.3 Guanhao Biotech Regenerative Medicine Introduction
12.15.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2018-2023)
12.15.5 Guanhao Biotech Recent Development
12.16 Mesoblast
12.16.1 Mesoblast Company Details
12.16.2 Mesoblast Business Overview
12.16.3 Mesoblast Regenerative Medicine Introduction
12.16.4 Mesoblast Revenue in Regenerative Medicine Business (2018-2023)
12.16.5 Mesoblast Recent Development
12.17 AMAG Pharmaceuticals (CBR)
12.17.1 AMAG Pharmaceuticals (CBR) Company Details
12.17.2 AMAG Pharmaceuticals (CBR) Business Overview
12.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Introduction
12.17.4 AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2018-2023)
12.17.5 AMAG Pharmaceuticals (CBR) Recent Development
12.18 ViaCord
12.18.1 ViaCord Company Details
12.18.2 ViaCord Business Overview
12.18.3 ViaCord Regenerative Medicine Introduction
12.18.4 ViaCord Revenue in Regenerative Medicine Business (2018-2023)
12.18.5 ViaCord Recent Development
12.19 CordLife
12.19.1 CordLife Company Details
12.19.2 CordLife Business Overview
12.19.3 CordLife Regenerative Medicine Introduction
12.19.4 CordLife Revenue in Regenerative Medicine Business (2018-2023)
12.19.5 CordLife Recent Development
12.20 Integra LifeSciences
12.20.1 Integra LifeSciences Company Details
12.20.2 Integra LifeSciences Business Overview
12.20.3 Integra LifeSciences Regenerative Medicine Introduction
12.20.4 Integra LifeSciences Revenue in Regenerative Medicine Business (2018-2023)
12.20.5 Integra LifeSciences Recent Development
12.21 Nuvasive
12.21.1 Nuvasive Company Details
12.21.2 Nuvasive Business Overview
12.21.3 Nuvasive Regenerative Medicine Introduction
12.21.4 Nuvasive Revenue in Regenerative Medicine Business (2018-2023)
12.21.5 Nuvasive Recent Development
12.22 Cook Biotech
12.22.1 Cook Biotech Company Details
12.22.2 Cook Biotech Business Overview
12.22.3 Cook Biotech Regenerative Medicine Introduction
12.22.4 Cook Biotech Revenue in Regenerative Medicine Business (2018-2023)
12.22.5 Cook Biotech Recent Development
12.23 Japan Tissue Engineering
12.23.1 Japan Tissue Engineering Company Details
12.23.2 Japan Tissue Engineering Business Overview
12.23.3 Japan Tissue Engineering Regenerative Medicine Introduction
12.23.4 Japan Tissue Engineering Revenue in Regenerative Medicine Business (2018-2023)
12.23.5 Japan Tissue Engineering Recent Development
13 Market Dynamics
13.1 Regenerative Medicine Industry Trends
13.2 Regenerative Medicine Market Drivers
13.3 Regenerative Medicine Market Challenges
13.4 Regenerative Medicine Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author List
15.3 Disclaimer
List of Tables
    Table 1. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million): (2018 VS 2022 VS 2029)
    Table 2. Major Players of Cell Therapy
    Table 3. Major Players of Tissue Engineering
    Table 4. Key Players of Biomaterial
    Table 5. Key Players of Other
    Table 6. Global Regenerative Medicine Market Size Growth by Application (2018 VS 2022 VS 2029)
    Table 7. Global Regenerative Medicine Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
    Table 8. Global Regenerative Medicine Revenue (US$ Million) Market Share by Region (2018-2023))
    Table 9. Global Regenerative Medicine Revenue Share by Region (2018-2023)
    Table 10. Global Regenerative Medicine Revenue (US$ Million) Forecast by Region (2024-2029)
    Table 11. Global Regenerative Medicine Revenue Share Forecast by Region (2024-2029)
    Table 12. Global Regenerative Medicine Revenue by Players (2018-2023) & (US$ Million)
    Table 13. Global Regenerative Medicine Revenue Share by Players (2018-2023)
    Table 14. Global Regenerative Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine as of 2022)
    Table 15. Ranking of Global Top Regenerative Medicine Companies by Revenue (US$ Million) in 2021
    Table 16. Global 5 Largest Players Market Share by Regenerative Medicine Revenue (CR5 and HHI) & (2018-2023)
    Table 17. Key Players Headquarters and Area Served
    Table 18. Key Players Regenerative Medicine Product Solution and Service
    Table 19. Date of Enter into Regenerative Medicine Market
    Table 20. Mergers & Acquisitions, Expansion Plans
    Table 21. Global Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
    Table 22. Global Regenerative Medicine Revenue Market Share by Type (2018-2023)
    Table 23. Global Regenerative Medicine Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 24. Global Regenerative Medicine Revenue Market Share by Type (2024-2029)
    Table 25. Global Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
    Table 26. Global Regenerative Medicine Revenue Market Share by Application (2018-2023)
    Table 27. Global Regenerative Medicine Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 28. Global Regenerative Medicine Revenue Market Share by Application (2024-2029)
    Table 29. United States Regenerative Medicine Revenue by Company (2018-2023) & (US$ Million)
    Table 30. United States Regenerative Medicine Revenue Market Share by Company (2018-2023)
    Table 31. United States Regenerative Medicine Market Size by Type (2018-2023) & (K Units)
    Table 32. United States Regenerative Medicine Market Size by Type (2024-2029) & (K Units)
    Table 33. United States Regenerative Medicine Market Size by Application (2018-2023) & (K Units)
    Table 34. United States Regenerative Medicine Market Size by Application (2024-2029) & (K Units)
    Table 35. Europe Regenerative Medicine Revenue by Company (2018-2023) & (US$ Million)
    Table 36. Europe Regenerative Medicine Revenue Market Share by Company (2018-2023)
    Table 37. Europe Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
    Table 38. Europe Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
    Table 39. Europe Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
    Table 40. Europe Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
    Table 41. China Regenerative Medicine Revenue by Company (2018-2023) & (US$ Million)
    Table 42. China Regenerative Medicine Revenue Market Share by Company (2018-2023)
    Table 43. China Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
    Table 44. China Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
    Table 45. China Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
    Table 46. China Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
    Table 47. Japan Regenerative Medicine Revenue by Company (2018-2023) & (US$ Million)
    Table 48. Japan Regenerative Medicine Revenue Market Share by Company (2018-2023)
    Table 49. Japan Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
    Table 50. Japan Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
    Table 51. Japan Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
    Table 52. Japan Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
    Table 53. Southeast Asia Regenerative Medicine Revenue by Company (2018-2023) & (US$ Million)
    Table 54. Southeast Asia Regenerative Medicine Revenue Market Share by Company (2018-2023)
    Table 55. Southeast Asia Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
    Table 56. Southeast Asia Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
    Table 57. Southeast Asia Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
    Table 58. Southeast Asia Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
    Table 59. India Regenerative Medicine Revenue by Company (2018-2023) & (US$ Million)
    Table 60. India Regenerative Medicine Revenue Market Share by Company (2018-2023)
    Table 61. India Regenerative Medicine Market Size by Type (2018-2023) & (US$ Million)
    Table 62. India Regenerative Medicine Market Size by Type (2024-2029) & (US$ Million)
    Table 63. India Regenerative Medicine Market Size by Application (2018-2023) & (US$ Million)
    Table 64. India Regenerative Medicine Market Size by Application (2024-2029) & (US$ Million)
    Table 65. J & J (DePuy Synthes) Company Details
    Table 66. J & J (DePuy Synthes) Description and Business Overview
    Table 67. J & J (DePuy Synthes) Regenerative Medicine Product
    Table 68. J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 69. J & J (DePuy Synthes) Recent Development
    Table 70. Medtronic Company Details
    Table 71. Medtronic Description and Business Overview
    Table 72. Medtronic Regenerative Medicine Product
    Table 73. Medtronic Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 74. Medtronic Recent Development
    Table 75. Zimmer Biomet Company Details
    Table 76. Zimmer Biomet Description and Business Overview
    Table 77. Zimmer Biomet Regenerative Medicine Product
    Table 78. Zimmer Biomet Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 79. Zimmer Biomet Recent Development
    Table 80. Stryker Company Details
    Table 81. Stryker Description and Business Overview
    Table 82. Stryker Regenerative Medicine Product
    Table 83. Stryker Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 84. Stryker Recent Development
    Table 85. Allergan(Acelity) Company Details
    Table 86. Allergan(Acelity) Description and Business Overview
    Table 87. Allergan(Acelity) Regenerative Medicine Product
    Table 88. Allergan(Acelity) Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 89. Allergan(Acelity) Recent Development
    Table 90. MiMedx Group Company Details
    Table 91. MiMedx Group Description and Business Overview
    Table 92. MiMedx Group Regenerative Medicine Product
    Table 93. MiMedx Group Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 94. MiMedx Group Recent Development
    Table 95. Organogenesis Company Details
    Table 96. Organogenesis Description and Business Overview
    Table 97. Organogenesis Regenerative Medicine Product
    Table 98. Organogenesis Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 99. Organogenesis Recent Development
    Table 100. Fujifilm Cellular Dynamics Company Details
    Table 101. Fujifilm Cellular Dynamics Regenerative Medicine Product
    Table 102. Fujifilm Cellular Dynamics Description and Business Overview
    Table 103. Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 104. Fujifilm Cellular Dynamics Recent Development
    Table 105. Osiris Therapeutics Company Details
    Table 106. Osiris Therapeutics Regenerative Medicine Product
    Table 107. Osiris Therapeutics Description and Business Overview
    Table 108. Osiris Therapeutics Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 109. Osiris Therapeutics Recent Development
    Table 110. Vcanbio Company Details
    Table 111. Vcanbio Description and Business Overview
    Table 112. Vcanbio Regenerative Medicine Product
    Table 113. Vcanbio Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 114. Vcanbio Recent Development
    Table 115. CCBC Company Details
    Table 116. CCBC Description and Business Overview
    Table 117. CCBC Regenerative Medicine Product
    Table 118. CCBC Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 119. CCBC Recent Development
    Table 120. Cytori Company Details
    Table 121. Cytori Description and Business Overview
    Table 122. Cytori Regenerative Medicine Product
    Table 123. Cytori Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 124. Cytori Recent Development
    Table 125. Celgene Company Details
    Table 126. Celgene Description and Business Overview
    Table 127. Celgene Regenerative Medicine Product
    Table 128. Celgene Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 129. Celgene Recent Development
    Table 130. Vericel Corporation Company Details
    Table 131. Vericel Corporation Description and Business Overview
    Table 132. Vericel Corporation Regenerative Medicine Product
    Table 133. Vericel Corporation Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 134. Vericel Corporation Recent Development
    Table 135. Guanhao Biotech Company Details
    Table 136. Guanhao Biotech Description and Business Overview
    Table 137. Guanhao Biotech Regenerative Medicine Product
    Table 138. Guanhao Biotech Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 139. Guanhao Biotech Recent Development
    Table 140. Mesoblast Company Details
    Table 141. Mesoblast Description and Business Overview
    Table 142. Mesoblast Regenerative Medicine Product
    Table 143. Mesoblast Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 144. Mesoblast Recent Development
    Table 145. AMAG Pharmaceuticals (CBR) Company Details
    Table 146. AMAG Pharmaceuticals (CBR) Description and Business Overview
    Table 147. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product
    Table 148. AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 149. AMAG Pharmaceuticals (CBR) Recent Development
    Table 150. ViaCord Company Details
    Table 151. ViaCord Description and Business Overview
    Table 152. ViaCord Regenerative Medicine Product
    Table 153. ViaCord Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 154. ViaCord Recent Development
    Table 155. CordLife Company Details
    Table 156. CordLife Description and Business Overview
    Table 157. CordLife Regenerative Medicine Product
    Table 158. CordLife Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 159. CordLife Recent Development
    Table 160. Integra LifeSciences Company Details
    Table 161. Integra LifeSciences Description and Business Overview
    Table 162. Integra LifeSciences Regenerative Medicine Product
    Table 163. Integra LifeSciences Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 164. Integra LifeSciences Recent Development
    Table 165. Nuvasive Company Details
    Table 166. Nuvasive Description and Business Overview
    Table 167. Nuvasive Regenerative Medicine Product
    Table 168. Nuvasive Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 169. Nuvasive Recent Development
    Table 170. Cook Biotech Company Details
    Table 171. Cook Biotech Description and Business Overview
    Table 172. Cook Biotech Regenerative Medicine Product
    Table 173. Cook Biotech Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 174. Cook Biotech Recent Development
    Table 175. Japan Tissue Engineering Company Details
    Table 176. Japan Tissue Engineering Description and Business Overview
    Table 177. Japan Tissue Engineering Regenerative Medicine Product
    Table 178. Japan Tissue Engineering Revenue in Regenerative Medicine Business (2018-2023) & (US$ Million)
    Table 179. Japan Tissue Engineering Recent Development
    Table 180. Regenerative Medicine Market Trends
    Table 181. Regenerative Medicine Market Drivers
    Table 182. Regenerative Medicine Market Challenges
    Table 183. Regenerative Medicine Market Restraints
    Table 184. Research Programs/Design for This Report
    Table 185. Key Data Information from Secondary Sources
    Table 186. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Regenerative Medicine Market Share by Type: 2022 VS 2029
    Figure 2. Cell Therapy Features
    Figure 3. Tissue Engineering Features
    Figure 4. Biomaterial Features
    Figure 5. Other Features
    Figure 6. Global Regenerative Medicine Market Share by Application: 2022 VS 2029
    Figure 7. Dermatology Case Studies
    Figure 8. Cardiovascular Case Studies
    Figure 9. CNS Case Studies
    Figure 10. Orthopedic Case Studies
    Figure 11. Others Case Studies
    Figure 12. Regenerative Medicine Report Years Considered
    Figure 13. Global Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 14. Global Regenerative Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Regenerative Medicine Revenue Market Share by Region: 2018 VS 2022
    Figure 16. United States Regenerative Medicine Revenue (Million USD) Growth Rate (2018-2029)
    Figure 17. Europe Regenerative Medicine Revenue (Million USD) Growth Rate (2018-2029)
    Figure 18. China Regenerative Medicine Revenue (Million USD) Growth Rate (2018-2029)
    Figure 19. Japan Regenerative Medicine Revenue (Million USD) Growth Rate (2018-2029)
    Figure 20. Southeast Asia Regenerative Medicine Revenue (Million USD) Growth Rate (2018-2029)
    Figure 21. India Regenerative Medicine Revenue (Million USD) Growth Rate (2018-2029)
    Figure 22. Global Regenerative Medicine Market Share by Players in 2022
    Figure 23. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2022)
    Figure 24. The Top 10 and 5 Players Market Share by Regenerative Medicine Revenue in 2022
    Figure 25. United States Regenerative Medicine Market Share by Type (2018-2029)
    Figure 26. United States Regenerative Medicine Market Share by Application (2018-2029)
    Figure 27. Europe Regenerative Medicine Market Share by Type (2018-2029)
    Figure 28. Europe Regenerative Medicine Market Share by Application (2018-2029)
    Figure 29. China Regenerative Medicine Market Share by Type (2018-2029)
    Figure 30. China Regenerative Medicine Market Share by Application (2018-2029)
    Figure 31. Japan Regenerative Medicine Market Share by Type (2018-2029)
    Figure 32. Japan Regenerative Medicine Market Share by Application (2018-2029)
    Figure 33. Southeast Asia Regenerative Medicine Market Share by Type (2018-2029)
    Figure 34. Southeast Asia Regenerative Medicine Market Share by Application (2018-2029)
    Figure 35. India Regenerative Medicine Market Share by Type (2018-2029)
    Figure 36. India Regenerative Medicine Market Share by Application (2018-2029)
    Figure 37. J & J (DePuy Synthes) Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 38. Medtronic Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 39. Zimmer Biomet Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 40. Stryker Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 41. Allergan(Acelity) Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 42. MiMedx Group Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 43. Organogenesis Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 44. Fujifilm Cellular Dynamics Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 45. Osiris Therapeutics Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 46. Vcanbio Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 47. CCBC Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 48. Cytori Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 49. Celgene Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 50. Vericel Corporation Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 51. Guanhao Biotech Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 52. Mesoblast Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 53. AMAG Pharmaceuticals (CBR) Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 54. ViaCord Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 55. CordLife Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 56. Integra LifeSciences Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 57. Nuvasive Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 58. Cook Biotech Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 59. Japan Tissue Engineering Revenue Growth Rate in Regenerative Medicine Business (2018-2023)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4000

This license allows only one user to access the PDF.
Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS